143 related articles for article (PubMed ID: 32312836)
21. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
Aristizabal Prada ET; Orth M; Nölting S; Spöttl G; Maurer J; Auernhammer C
PLoS One; 2017; 12(5):e0178375. PubMed ID: 28542590
[TBL] [Abstract][Full Text] [Related]
22. Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588.
Wang JY; Jin L; Yan XG; Sherwin S; Farrelly M; Zhang YY; Liu F; Wang CY; Guo ST; Yari H; La T; McFarlane J; Lei FX; Tabatabaee H; Chen JZ; Croft A; Jiang CC; Zhang XD
J Invest Dermatol; 2016 Nov; 136(11):2277-2286. PubMed ID: 27427486
[TBL] [Abstract][Full Text] [Related]
23. Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1.
Lee Y; Onishi Y; McPherson L; Kietrys AM; Hebenbrock M; Jun YW; Das I; Adimoolam S; Ji D; Mohsen MG; Ford JM; Kool ET
ACS Chem Biol; 2022 Aug; 17(8):2074-2087. PubMed ID: 35830623
[TBL] [Abstract][Full Text] [Related]
24. Overexpressed c-Myc Sensitizes Cells to TH1579, a Mitotic Arrest and Oxidative DNA Damage Inducer.
Henriksson S; Calderón-Montaño JM; Solvie D; Warpman Berglund U; Helleday T
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551206
[TBL] [Abstract][Full Text] [Related]
25. Potent and specific MTH1 inhibitors targeting gastric cancer.
Zhou W; Ma L; Yang J; Qiao H; Li L; Guo Q; Ma J; Zhao L; Wang J; Jiang G; Wan X; Adam Goscinski M; Ding L; Zheng Y; Li W; Liu H; Suo Z; Zhao W
Cell Death Dis; 2019 Jun; 10(6):434. PubMed ID: 31164636
[TBL] [Abstract][Full Text] [Related]
26. Suppression of mutagenesis by 8-hydroxy-2'-deoxyguanosine 5'-triphosphate (7,8-dihydro-8-oxo-2'-deoxyguanosine 5'-triphosphate) by human MTH1, MTH2, and NUDT5.
Hori M; Satou K; Harashima H; Kamiya H
Free Radic Biol Med; 2010 May; 48(9):1197-201. PubMed ID: 20144704
[TBL] [Abstract][Full Text] [Related]
27. Investigation of micronucleus induction in MTH1 knockdown cells exposed to UVA, UVB or UVC.
Fotouhi A; Cornella N; Ramezani M; Wojcik A; Haghdoost S
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():161-5. PubMed ID: 26520386
[TBL] [Abstract][Full Text] [Related]
28. [Proliferation-Inhibitory and Apoptosis-Inducing Effects of Targeting MTH1 on Multiple Myeloma Cells].
Wang X; Wu Y; Zhang L; Li YX; Han B; Shi X; Wang W; Wang LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1598-1604. PubMed ID: 33067960
[TBL] [Abstract][Full Text] [Related]
29. MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides.
Nakabeppu Y; Kajitani K; Sakamoto K; Yamaguchi H; Tsuchimoto D
DNA Repair (Amst); 2006 Jul; 5(7):761-72. PubMed ID: 16621731
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of MTH1 inhibition-induced DNA strand breaks: The slippery slope from the oxidized nucleotide pool to genotoxic damage.
Rai P; Sobol RW
DNA Repair (Amst); 2019 May; 77():18-26. PubMed ID: 30852368
[TBL] [Abstract][Full Text] [Related]
31. Oxidized nucleotide insertion by pol β confounds ligation during base excision repair.
Çağlayan M; Horton JK; Dai DP; Stefanick DF; Wilson SH
Nat Commun; 2017 Jan; 8():14045. PubMed ID: 28067232
[TBL] [Abstract][Full Text] [Related]
32. OGG1, MYH and MTH1 gene variants identified in gastric cancer patients exhibiting both 8-hydroxy-2'-deoxyguanosine accumulation and low inflammatory cell infiltration in their gastric mucosa.
Goto M; Shinmura K; Yamada H; Tsuneyoshi T; Sugimura H
J Genet; 2008 Aug; 87(2):181-6. PubMed ID: 18776649
[No Abstract] [Full Text] [Related]
33. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes.
Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T
DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017
[TBL] [Abstract][Full Text] [Related]
34. Understanding the molecular mechanism for the differential inhibitory activities of compounds against MTH1.
Wang M; Zhou S; Chen Q; Wang L; Liang Z; Wang J
Sci Rep; 2017 Jan; 7():40557. PubMed ID: 28074893
[TBL] [Abstract][Full Text] [Related]
35. The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors.
Samaranayake GJ; Troccoli CI; Zhang L; Huynh M; Jayaraj CJ; Ji D; McPherson L; Onishi Y; Nguyen DM; Robbins DJ; Karbaschi M; Cooke MS; Barrientos A; Kool ET; Rai P
Mol Cancer Ther; 2020 Feb; 19(2):432-446. PubMed ID: 31744893
[TBL] [Abstract][Full Text] [Related]
36. MTH1 as a nucleotide pool sanitizing enzyme: Friend or foe?
Nakabeppu Y; Ohta E; Abolhassani N
Free Radic Biol Med; 2017 Jun; 107():151-158. PubMed ID: 27833032
[TBL] [Abstract][Full Text] [Related]
37. Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase.
Nakabeppu Y; Oka S; Sheng Z; Tsuchimoto D; Sakumi K
Mutat Res; 2010 Nov; 703(1):51-8. PubMed ID: 20542142
[TBL] [Abstract][Full Text] [Related]
38. Oxidation of mitochondrial deoxynucleotide pools by exposure to sodium nitroprusside induces cell death.
Ichikawa J; Tsuchimoto D; Oka S; Ohno M; Furuichi M; Sakumi K; Nakabeppu Y
DNA Repair (Amst); 2008 Mar; 7(3):418-30. PubMed ID: 18155646
[TBL] [Abstract][Full Text] [Related]
39. The genomic landscape of 8-oxodG reveals enrichment at specific inherently fragile promoters.
Gorini F; Scala G; Di Palo G; Dellino GI; Cocozza S; Pelicci PG; Lania L; Majello B; Amente S
Nucleic Acids Res; 2020 May; 48(8):4309-4324. PubMed ID: 32198884
[TBL] [Abstract][Full Text] [Related]
40. Human MTH1 protein hydrolyzes the oxidized ribonucleotide, 2-hydroxy-ATP.
Fujikawa K; Kamiya H; Yakushiji H; Nakabeppu Y; Kasai H
Nucleic Acids Res; 2001 Jan; 29(2):449-54. PubMed ID: 11139615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
